BioProduction 2010

Protein Characterisation (CQ3423)

Regulators expect companies to analyse their products far earlier and in far greater detail than ever before. The aim of this conference is to highlight the key technologies and issues facing analytical departments in meeting this demand and also the important role analytics plays in improving process developments. Key topics include the emergence of HX-MS and NMR in defining Higher Order Structures; Setting Critical Quality Attributes; Enabling High-Concentration Formulations; plus Stability at the Fill and Finish Stage.

Concerns over higher order structures are forcing companies to re-consider their analytical strategies and choice of instrumentation. Make sure you aren’t left behind in the race to satisfy ever demanding regulatory expectations

Professor John R. Engen, Associate Professor of Chemistry & Chemical Biology, Northeastern University, USA
Dr. Edward R. Zartler, Research Fellow, Merck, USA
Dr Fiona Greer, Director of Biochemical Services, M-Scan.Ltd, UK
Mr Antonio Datola, Researcher, Structural Characterisation, Merck Serono, Italy
Dr Rune Salbo, Researcher, Novo Nordisk, Denmark
Dr Nelly Viseux, Associate Director, Analytical Development, Shire, USA
Dr Anne Kowal, Associate Director, Millennium Pharmaceuticals, USA

Key reasons to attend Informa Life Sciences’ Protein Characterisation conference

· Hear the latest on HX-MS, the new “analytical platform on the block”, and its impressive role in aiding comparability studies and defining protein conformation

· Find out how NMR is being used to improve our knowledge of proteins – Merck’s Teddy Zartler reveals all

· Merck Serono highlights the important role MS plays in supporting process development

· Shire and Millennium Pharmaceuticals explain their approach to setting Critical Quality Attributes and the issues must overcome

· Compare your protein aggregation detection methods with case studies from MedImmune and Abbott

· Overcome issues relating to high-concentration formulations and how stability is monitored during the Fill and Finish Stage

· Hear Synthon’s novel technique for optimising process development and Genzyme’s approach to profiling process characterisation

Recommended Workshops

Tuesday 26 October 2010

Workshop V: Product Characterisation of Biopharmaceuticals for Regulatory Requirements

WORKSHOP LEADERS
Dr Andrew Reason, Managing Director, M-Scan Ltd, UK & M-Scan GmbH, Germany
Dr Fiona Greer, Global Director, Quality Assurance, M-Scan Group.

Click Here for the full agenda

Friday 29 October 2010

Workshop Z: Practical Aspects of Protein Characterisation for Bioprocessing

WORKSHOP LEADER
Dr. Christine P. Chan, Senior Manager, Bioanalytics & Formulation, Genzyme Corporation, USA

Click Here for the full agenda

Quite interesting in current technology information
(Genhelix Spain)

Very interesting and focusing
(ROUICM)

Instantaneous Industrial Nice Picture = The event contains all the relevant information I need to know today.
(Merck Serono Biodevelopment)

In general interesting
(CEVEC Pharmaceuticals)

Well conducted and useful conference. Good speakers and nice location.
(DSM Biologics BV)

A clever interface between basic science and production.
(Medicago inc)

A resumé of the most important items in biotech forums.
(Genhelix Spain)

Very good overview of current industry practices and areas of interest.
(Pfizer Inc)

Large and diverse conference, maybe too large. Excellent, driven speakers.
(Toxicon)

Good event in a nice city.
(NNE Pharmaplan)

Very high quality presentations. A clear picture of QbD for biotechs.
(Sanofi-Aventis)

It was ok, but I took a number of useful notes.
(ETH Zurich)

Workshops were good and informative
(Teva Pharmaceuticals)

Interesting, my first EU conference.
(Sandoz)

Interesting speakers, well arranged, good networking opportunities.
(GE Healthcare)

Excellent organization, good selection of speakers. Some focus on drug product regulatory and quality would be appreciated. Nice venue facility.
(Kuros Biosurgery AG)

A great opportunity to network and meet up with colleagues.
(Biopharm Services)

Good networking opportunities and useful for viewing future Bioproduction trends.
(Laboratorios Hipra SA)

Very informative conference in a beautiful city.
(Centocor)

Excellent in depth coverage of subject areas.
(Domantis Ltd)

Good organisation and good opportunity for
networking. Interesting technical presentations.
(GlaxoSmithKline Biologicals)

Good networking, content level useful, some conferences better than other
(Sealed Air)

Excellent event! The possibility to switch between four conferences made the attendance most valuable for me!
(Suppremol)

The conference is perfectly organised, enabling highly efficient exchange among the participants.
(Novartis Biologics)

Very useful and well organised.
(GlaxoSmithKline R&D)

Good condensed update on the state and trends of the Bioproduction Business.
(Merck Serono)

Focused – good technical and process content.
(LFB Biotechnologies)

This was an interesting opportunity to speak to a variety of QbD experts and to hear what we should incorporate in our Masters programme.
(De Montfort University)

Event Links

Conference

Sponsorship

Exhibitors

Media Partners

Marketing Tools

Protein Characterisation (CQ3423)

Recommended Workshops

Corporate Sponsors

Associate Sponsor